SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,193,658 | +2.5% | 684,392 | -7.0% | 0.03% | +6.7% |
| Q2 2023 | $141,696,246 | -14.8% | 736,238 | -10.4% | 0.03% | -16.7% |
| Q1 2023 | $166,328,655 | +49.2% | 821,498 | -5.3% | 0.04% | +44.0% |
| Q4 2022 | $111,457,076 | -19.2% | 867,303 | -14.0% | 0.02% | -24.2% |
| Q3 2022 | $137,952,000 | -19.3% | 1,008,200 | +4.4% | 0.03% | -15.4% |
| Q2 2022 | $170,851,000 | +26.2% | 965,592 | +2.8% | 0.04% | +50.0% |
| Q1 2022 | $135,336,000 | -10.3% | 939,506 | -3.7% | 0.03% | -3.7% |
| Q4 2021 | $150,861,000 | -11.9% | 975,824 | -3.2% | 0.03% | -18.2% |
| Q3 2021 | $171,250,000 | +8.8% | 1,008,537 | +1.2% | 0.03% | +10.0% |
| Q2 2021 | $157,353,000 | +13.0% | 996,672 | -0.6% | 0.03% | +7.1% |
| Q1 2021 | $139,194,000 | -22.5% | 1,002,400 | -2.3% | 0.03% | -28.2% |
| Q4 2020 | $179,602,000 | – | 1,025,482 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |